TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Participate, Present at Upcoming Virtual Investor Spotlight Event
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be presenting at an upcoming Virtual Investor Spotlight Event. The event is titled Virtual Investor Spotlight Event - Rapidly Advancing GBM Pivotal Study. According to the announcement, the live, moderated video webcast is scheduled to begin at noon on May 3, 2023, and will feature members of CNS Pharmaceuticals management, including CEO John Climaco; chief medical officer Sandra Silberman, MD, PhD; and VP of clinical operations Zena Muzyczenko. These key executives will discuss the progress…